Brief: Atreca - Under Agreement, Gates Mri Will Lead Development Of Mam01/Atrc-501

Atreca

21/10/2021 14:13

Oct 21 (Reuters) - Atreca Inc  BCEL.O :
    * ATRECA ENTERS INTO LICENSING AGREEMENT WITH BILL & MELINDA
GATES
MEDICAL RESEARCH INSTITUTE TO DEVELOP A MONOCLONAL ANTIBODY FOR
THE PREVENTION OF MALARIA
    * ATRECA - UNDER AGREEMENT, GATES MRI WILL LEAD DEVELOPMENT
OF
MAM01/ATRC-501
    * ATRECA INC - UNDER AGREEMENT, GATES MRI WILL RECEIVE
COMMERCIAL
RIGHTS IN GAVI-ELIGIBLE COUNTRIES LOCATED IN MALARIA-ENDEMIC
REGIONS OF WORLD
    * ATRECA INC - ATRECA WILL RETAIN COMMERCIAL RIGHTS FOR
MAM01/ATRC-501 IN U.S., EUROPE AND PARTS OF ASIA

Source text for Eikon:  ID:nGNX3DjS5M 
Further company coverage:  BCEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))